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Acute kidney injury is a frequent and serious compli-
cation of sepsis. To better understand the develop-
ment of sepsis-induced acute kidney injury, we per-
formed the first time-dependent studies to document
changes in renal hemodynamics and oxidant genera-
tion in the peritubular microenvironment using the
murine cecal ligation and puncture (CLP) model of
sepsis. CLP caused an increase in renal capillary per-
meability at 2 hours, followed by decreases in mean
arterial pressure, renal blood flow (RBF), and renal
capillary perfusion at 4 hours, which were sustained
through 18 hours. The decline in hemodynamic pa-
rameters was associated with hypoxia and oxidant
generation in the peritubular microenvironment and
a decrease in glomerular filtration rate. The role of
oxidants was assessed using the superoxide dismu-
tase mimetic/peroxynitrite scavenger MnTMPyP
[Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin]. At 10
mg/kg administered 6 hours after CLP, MnTMPyP did
not alter blood pressure, but blocked superoxide and
peroxynitrite generation, reversed the decline in RBF,
capillary perfusion, and glomerular filtration rate, pre-
served tubular architecture, and increased 48-hour sur-
vival. However, MnTMPyP administered at CLP did not
prevent capillary permeability or the decrease in RBF
and capillary perfusion, which suggests that these early
events are not mediated by oxidants. These data dem-
onstrate that renal hemodynamic changes occur early
after sepsis and that targeting the later oxidant genera-
tion can break the cycle of injury and enable the micro-circulation and renal function to recover. (Am J Pathol
2012, 180:505–516; DOI: 10.1016/j.ajpath.2011.10.011)
Acute kidney injury (AKI) is one of the most serious com-
plications of sepsis because it worsens prognosis and
increases cost of care. The incidence of AKI increases
with the severity of sepsis and the mortality for septic
patients with AKI is approximately doubled to near 70%
compared with patients with sepsis alone.1 It is estimated
that AKI develops within the first 24 hours in 64% of
patients with sepsis with hypotension.2 Thus, protecting
the kidney during sepsis could significantly reduce mor-
bidity and mortality in patients with severe sepsis. Treat-
ment of sepsis and especially of sepsis-induced AKI has
advanced little during the last several decades.3 The
standard of care is primarily supportive, with fluid resus-
citation, broad-spectrum antibiotic therapy, lung-protec-
tive ventilation, and, if necessary, dialysis. Treatment is
approached in two phases: resuscitation within the first 6
hours and management within the first 24 hours, and has
improved survival, although mortality remains high.4
A barrier to uncovering new specific therapeutic ap-
proaches for sepsis-induced AKI is lack of understanding
of the temporal and mechanistic relationships between
the changes in renal hemodynamics, peritubular micro-
circulatory dysfunction, and renal tubular injury. These
are critical issues because, in general, the severity of
microvascular dysfunction correlates with patient mortal-
ity,5,6 and the timing of treatment, especially regarding
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its success.7 To help address this need, we performed a
detailed time course study to characterize the develop-
ment of microvascular dysfunction during sepsis-in-
duced AKI using the clinically relevant cecal ligation and
puncture (CLP) model in aged mice.8
It is becoming increasingly clear that oxidative stress
and microvascular dysfunction have important roles in
the development of multiple-organ failure during sep-
sis.9,10 Severely ill patients with sepsis demonstrate in-
creased oxidative stress markers11,12 and reduced
microvascular perfusion.13 The role of oxidants in sepsis-
induced AKI is supported by animal studies in which
inhibiting NO-derived reactive nitrogen species (RNS)
such as peroxynitrite (the product of NO and superoxide)
reduces tubular injury and preserves renal function in
both lipopolysaccharide and CLP models of sepsis.14–16
However, the relationship between renal microvascular
changes and oxidant generation has not been directly stud-
ied. To investigate this, the therapeutic potential of the su-
peroxide dismutase mimetic and peroxynitrite scavenger
MnTMPyP [Mn(III)tetrakis(1-methyl-4-pyridyl) porphyrin, tet-
ratosylate, hydroxide]17,18 was evaluated in the CLP model
using a delayed dosing protocol.
Materials and Methods
Materials
Fluorescein isothiocyanate–dextran 500,000 Da conjugate
(FITC-dextran), FITC-inulin, xanthine, xanthine oxidase, cy-
tochrome c, and Evans Blue dye were purchased from
Sigma-Aldrich Corp. (St. Louis, MO). 2-(3,6-Diamino-9H-
xanthen-9-yl)–benzoic acid, methyl ester [dihydrorhod-
amine 123 (DHR-123)], and MitoSOX Red were purchased
from Invitrogen Corp. (Eugene, OR). MnTMPyP was pur-
chased from EMD-Calbiochem (La Jolla, CA).
Mouse Model of CLP-Induced AKI
Sepsis was CLP-induced as described previously.14
Male C57/BL6 mice (Harlan Laboratories, Inc., Indianap-
olis, IN) at 39 to 40 weeks of age were acclimated for 1
week with free access to food and water. At surgery, the
mice were anesthetized via isoflurane inhalation. After
laparotomy, a 4–0 silk ligature was placed 1.5 cm from
the cecal tip. The cecum was punctured twice using a
21-gauge needle and gently squeezed to express an
approximately 1-mm column of fecal material (CLP mice).
In sham-operated mice (Sham), the cecum was located
but neither ligated nor punctured. The abdominal incision
was closed in two layers using 4–0 silk sutures. After
surgery, 1 mL warmed normal saline solution was admin-
istered into the intraperitoneal cavity. Mice were then
placed in individual cages and set on a warming pad.
Mice studied at 18 hours after CLP received imipenem-
cilastatin (14 mg/kg s.c.) in 1.5 mL two-thirds normal
saline solution (40 mL/kg) for fluid resuscitation8 at 6
hours after CLP. All animals were housed and sacrificed
in accordance with the National Institutional of Health
Guide for the Care and Use of laboratory Animals and withapproval of the University of Arkansas for Medical Sci-
ences Institutional Animal Care and Use Committee.
Measurements of Systemic Mean Arterial Blood
Pressure and Heart Rate
Mean arterial pressure (MAP) and heart rate (HR) were
measured in conscious mice using biotelemetry. Telemetry
transmitters (Data Sciences International, Inc., St. Paul, MN)
were implanted into the carotid artery of the mice under
isoflurane anesthesia. After 4 days, mice were again anes-
thetized using isoflurane and underwent either CLP or sham
surgery. At 6 hours after surgery, mice received antibiotic
therapy and fluid resuscitation as described. Cardiovascu-
lar parameters were recorded every 5 minutes through 18
hours after CLP or sham surgery.
Renal Blood Flow
With the mice under isoflurane anesthesia, the right kid-
ney was exposed using a flank incision, and the renal
artery and vein were carefully dissected from surround-
ing tissue using Dumont No. 5 forceps. The renal artery
was isolated from the vein, and a Doppler flow probe (0.5
PSL renal artery flow probe; Transonic Systems, Inc.,
Ithaca, NY) was positioned around the renal artery. The
probe was calibrated in distilled water using the zero and
scale setting of the TS420 flowmeter (Transonic Systems,
Inc.). Body temperature was monitored using a rectal
probe, and was maintained at 36°C to 37°C using a
heating lamp. Blood flow readings were recorded using
commercially available software (PowerLab and Lab-
Chart; ADInstruments, Ltd., Sydney, Australia) for 10 min-
utes after the flow had stabilized. Renal blood flow (RBF)
was averaged over the 10-minute measurement period,
and was expressed in milliliters per minute per gram
kidney weigh (right kidney).
Glomerular Filtration Rate
Glomerular filtration rate (GFR) was measured using the
single-bolus FITC-inulin clearance method.19 In brief,
mice were injected with a 5% FITC-inulin solution in nor-
mal saline vehicle at a dose of 3.74 L/g via the tail vein.
Blood (25 L) was collected in heparinized capillary
tubes at 3, 7, 10, 15, 35, 55, 75, 90, and 120 minutes after
injection. FITC-inulin was measured at 485 nm excitation
and 538 emission, and was quantified against a standard
curve. Inulin clearance was calculated using a two-phase
decay nonlinear regression analysis. GFR was calculated
using the fast and slow phases of inulin clearance after
normalizing to the combined weight of both kidneys, as
described elsewhere.19
Serum Nitrate/Nitrite Concentrations
Serum nitrate/nitrite (NOx) concentrations, used as a
marker of systemic NO generation, were determined us-
ing the Total Nitric Oxide Assay Kit (Assay Designs, Inc.,
Ann Arbor, MI) as directed by the manufacturer. In brief,
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nitrate reductase. Data were expressed as serum NOx
concentration in micromolar.
Intravital Videomicroscopy
Intravital videomicroscopy (IVVM) of the mouse kidneys
was performed as previously described.14,15,20,21 In
brief, mice were anesthetized using isoflurane, and the
left kidney was exposed via a flank incision. The kidney
was positioned on a glass stage above an Axiovert 200
inverted fluorescence microscope equipped with an
Axiocam HSm digitizing camera (both from Carl Zeiss
AG, Jena, Germany) and kept moist using saline solution,
and were covered. During the entire IVVM procedure,
core temperature was monitored using a rectal tempera-
ture probe, and was maintained at 36°C to 37°C using an
infrared heat lamp. At the end of IVVM, blood was col-
lected from the inferior vena cava, and the mouse was
sacrificed via cervical dislocation. The right kidney was
fixed in 10% phosphate-buffered formalin.
Evaluation of Renal Peritubular Capillary
Perfusion
At 10 minutes before IVVM, mice were administered
FITC-dextran (500,000 Da, 2 mol/kg) with DHR-123 (1.1
mg/kg) or MitoSOX (1.67 mg/kg) in a total volume of 3
mL/kg via the penile vein. During IVVM, the renal intra-
vascular space and red blood cell movement were visu-
alized with FITC-dextran using an excitation of 470 nm
and an emission of 520 nm. For each mouse, five 10-
second videos were captured at approximately 30
frames per second from five randomly selected fields of
view. Capillary perfusion was analyzed as described pre-
viously.14 In brief, approximately 150 randomly selected
vessels per kidney were classified into three categories
of blood perfusion: “continuous flow,” in which red blood
cell movement in the vessel was not interrupted during
the video; “intermittent flow,” in which red blood cell
movement stopped or reversed at any time during the
video; and “no flow,” in which no red blood cell move-
ment was detected. Data were expressed as the percent-
age of vessels in each of the three categories.
Evaluation of Renal Tubular Epithelial Cell RNS
and Superoxide Generation Using IVVM
DHR-123 is oxidized to fluorescent rhodamine preferen-
tially by the RNS peroxynitrite.22 MitoSOX Red is a triph-
enylphosphonium derivative of dihydroethidine, which
targets it to the mitochondria, where oxidation by super-
oxide and possibly other reactive oxygen species (ROS)
yields a fluorescent product.23 Rhodamine or MitoSOX
fluorescence was visualized at 535 nm excitation and 590
nm emissions, and captured during IVVM from five ran-
domly selected fields of view (200 magnification) using
a 500-msec exposure. Fluorescence intensity of each
image was quantified using AxioVision Image Software
(Carl Zeiss AG) after subtracting background fluores-cence intensity. Data were expressed as arbitrary units
per square micrometer.
Assay for Superoxide Scavenging Activity
The ability of MnTMPyP to scavenge superoxide was
assessed by monitoring reduction of cytochrome c by
superoxide generated from xanthine/xanthine oxidase as
described elsewhere.17 In brief, superoxide generation
was initiated by adding xanthine oxidase (0.23 U/mL) to
the reaction solution containing 50 mmol/L phosphate
buffer (pH 7.8), 1 mmol/L EDTA, 40 mol/L xanthine, and
11 mol/L cytochrome c. After obtaining the initial rate
of reduction of cytochrome c measured at 550 nm,
MnTMPyP was added in varying concentrations. After the
addition of MnTMPyP, the change in the rate of reduction
of cytochrome c was determined. The data were ex-
pressed as percent inhibition of the initial rate of reduc-
tion of cytochrome c for each concentration of MnTMPyP.
From these data, the IC50 value (half maximal inhibitory
concentration) for MnTMPyP was calculated.
Evaluation of Renal Tubular Epithelial Redox
Stress Using IVVM
NADPH autofluorescence was used as an indicator of
cellular redox stress.24,25 NADPH autofluorescence was
visualized at 365 nm excitation and 420 nm emission, and
captured from five randomly selected fields of view
(200) using a 500-msec exposure. Fluorescence inten-
sity of each image was quantified using AxioVision Image
Software (Carl Zeiss AG) after subtracting background
fluorescence intensity. Data were expressed as arbitrary
units per square micrometer.
Assessment of Renal Microvascular
Permeability Using Evans Blue Dye
Renal microvascular permeability was assessed as de-
scribed by Yasuda et al26 with slight modifications. At 30
minutes before sacrifice, mice were injected with Evans
Blue dye (1% in 0.9% saline solution) at 2 mL/kg via the
tail vein. At sacrifice, mice were perfused using 30 mL
PBS through the left ventricle until all blood was removed.
The right kidney was weighed, homogenized in 1 mL
formamide, and incubated at 55°C for 18 hours. The
supernatant was collected after centrifugation at
12,000 g for 30 minutes. The amount of Evans Blue dye
in the supernatant was determined by measuring absor-
bance at 620 nm and correcting for turbidity at 740 nm,
as described by Moitra et al27 Evans Blue dye concen-
trations were determined from a standard curve and ex-
pressed as micrograms per gram kidney wet weight
(right kidney).
Evaluation of Renal Tubular Hypoxia
Renal hypoxia was assessed using the Hypoxyprobe-1
Plus Kit (Natural Pharmacia International, Inc., Burlington,
MA). The probe, pimonidazole (PIM), is reductively acti-
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cellular proteins.28 Thus, immunoreactive adducts form in
areas of low oxygen tension. PIM was administered at 60
mg/kg i.p. at 120 minutes before sacrifice. The left kidney
was harvested and fixed in formalin for 24 hours. Fixed
kidneys embedded in paraffin were cut into 5-m sec-
tions and stained for PIM adducts. After rehydration, an-
tigens were unmasked in 10 mmol/L sodium citrate (pH
6.0), heated to 95°C for 30 minutes, and allowed to cool.
Slides were then blocked with serum-free protein block
(Dako Corp., Carpinteria, CA), followed by addition of
Hypoxyprobe-1 FITC-MAB1 antibody diluted 1:125, and
incubated for 30 minutes at room temperature in a humid
chamber. Peroxidase-conjugated anti-FITC secondary
antibody diluted 1:125 was added, and the slides were
incubated for 30 minutes at room temperature. A chro-
mogen reagent supplied in the LSAB System–HRP Kit
(Dako Corp.) was used to visualize antigen binding. Kid-
ney sections were counterstained using Gill hematoxylin.
Nitrotyrosine Staining
Fixed kidneys embedded in paraffin were cut into 5-m
sections and stained for nitrotyrosine-protein adducts.
After rehydration, antigens were unmasked in 10 mmol/L
sodium citrate (pH 6.0), heated to 95°C for 30 minutes,
and allowed to cool. Slides were then blocked with se-
rum-free protein block (Dako Corp.), followed by addition
of polyclonal anti-nitrotyrosine antibody (Millipore Corp.,
Billerica, MA) diluted 1:500. After overnight at 4°C in a
humid chamber, slides were washed and incubated with
secondary antibody from the LSAB System–HRP kit
(Dako Corp.). A chromogen reagent supplied in the
LSAB System–HRP Kit was used to visualize antigen
binding. Nonspecific binding of the anti-nitrotyrosine an-
tibody was determined by preincubating the antibody
with 1 mmol/L 3-nitrotyrosine. Kidney sections were coun-
terstained using Gill hematoxylin.
Serum Urea Nitrogen, Creatinine, and Alanine
Aminotransferase
Blood urea nitrogen (BUN) and creatinine concentrations
in serum were measured using the QuantiChrom Urea
Assay Kit and the Creatinine Assay Kit, respectively (Bio-
Assay Systems LLC, Hayward, CA). Alanine aminotrans-
ferase was measured using a Cobas Mira Clinical Ana-
lyzer (Roche Diagnostic Systems, Inc., Branchburg, NJ).
Data were expressed as serum BUN and serum creati-
nine (SCr) concentrations in milligrams per deciliter, and
serum alanine aminotransferase concentration in interna-
tional units per liter.
Renal Tubular Injury Score
Paraffin-embedded sections (5 m) were prepared from
kidneys fixed in 10% phosphate-buffered formalin. PAS
stain was used for analysis of tubular architecture, with light
microscopy (Nikon E800; Nikon Instruments, Inc., Melville,
NY). Sections were scored in a blinded semiquantitativemanner using an established scoring scale.29 For each
animal, at least 10 high-power (400) fields were exam-
ined. The percentage of tubules that exhibited cellular ne-
crosis, loss of brush border, cast formation, vacuolization,
and tubule dilation were scored as follows: 0  none, 1 
10%, 2 11% to 25%, 3 26% to 45%, 4 46% to 75%,
and 5  76%.
MnTMPyP Treatment
MnTMPyP, a cell membrane–permeable superoxide dis-
mutase mimetic and peroxynitrite scavenger17,18 was
evaluated at a dose of 10 mg/kg in normal saline solution
(0.9% NaCl i.p.). This dose was based on previous stud-
ies using MnTMPyP and other manganese porphyrins in
rodents.16,30,31 Mice were treated with MnTMPyP or sa-
line solution immediately after CLP (0 hours) or at 6 hours
after CLP.
Survival Study
Mice subjected to CLP were administered either MnTMPyP
(10 mg/kg i.p.) or saline solution at 6 hours after CLP, and
were monitored for 48 hours. Core body temperature was
used as an indicator of pending death32 and was mea-
sured every 6 hours using a rectal probe. Mice were
considered nonsurvivors if they died or had to be eutha-
nized because of two consecutive core temperature
readings of less than 28°C.
Statistical Analysis
Data describing vessel flow were transformed using ad-
ditive log-ratio transformations. Multivariate multiple re-
gression analysis was used to evaluate changes in vessel
composition as a function of time since CLP. The model
included linear and quadratic functions of time to model
the curvature present in the data. Similarly, multivariate
analysis of variance models was used to evaluate vessel
composition data for experiments investigating the ef-
fects of MnTMPyP on CLP. The Tukey-Kramer method
was used to adjust for multiple comparisons. Hemody-
namic data obtained at telemetry were analyzed using
two-way analysis of variance. Other data with three or
more groups were analyzed using one-way analysis of
variance followed by the Newman-Keuls or Dunnett post
hoc tests, with the exception of the renal tubular injury
scores, which were analyzed using the nonparametric
Kruskal-Wallis test followed by the Dunn multiple-com-
parisons test. Survival curve was analyzed using a Man-
tel-Cox log-rank test. Statistical significance was consid-
ered at P  0.05.
Results
Hemodynamic Changes after CLP
To measure the systemic hemodynamic changes during
sepsis in older C57BL mice subjected to CLP, we re-
corded MAP and HR in conscious mice using telemetry
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remained relatively stable at 100 to 120 mm Hg before
and after sham surgery. In contrast, MAP in CLP mice
was significantly lower compared with that in Sham mice.
MAP declined rapidly during the first 6 hours to approx-
imately 60 mm Hg, a value below the minimal renal au-
toregulatory pressure reported for the mouse.33 MAP
then slowly increased to approximately 85 mm Hg by 12
hours, and remained relatively stable through 18 hours.
Like MAP, HR did not change in Sham mice. In CLP mice,
HR decreased significantly compared with that in Sham
mice; however, the decrease was delayed relative to the
decrease in MAP.
Increased systemic NO synthesis accompanying hy-
potension is a feature of sepsis in humans.34 The time
course of serum NOx concentration in mice subjected to
CLP is shown in Figure 1C. Because NOx concentrations
in serum from Sham mice at 6 and 18 hours were not
different, the value for Sham mice is from pooled data.
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Figure 1. Systemic hemodynamic responses and serum nitrite/nitrate levels
in mice after CLP. MAP (A) and HR (B) were recorded using biotelemetry
after CLP or sham surgery. Fluids and antibiotics were administered at 6
hours after surgery (Materials and Methods). Data are given as mean  SEM
for 4 to 8 mice per group. *P  0.05 compared with Sham. C: Time course of
change in serum NOx levels. Data are given as mean  SEM for 5 to 11 mice
per group. *P  0.05 compared with Sham.NOx levels were significantly elevated at 4 hours afterCLP compared with sham surgery, and were sustained
through 18 hours.
Renal Capillary Dysfunction
The time course of changes in renal cortical capillary
perfusion during sepsis was assessed using IVVM. Renal
peritubular capillary perfusion declined rapidly after CLP
(Figure 2A). The distribution of vessels with continuous,
intermittent, and no flow changed over time, reaching
significance by 4 hours, compared with the Sham control
group (pooled data from 6 and 18 hours for Sham mice).
Vessels with continuous flow decreased from 87%  3%
in Shammice to 53% 5% in CLP mice. This decline was
accompanied by an increase in the percentage of ves-
sels with no flow, from 7%  1% in Sham mice to 29% 
4% in CLP mice. The impaired renal capillary perfusion
was sustained through 18 hours.
RBF and GFR after CLP
The time course of changes in RBF during sepsis is
shown in Figure 2B. RBF in CLP mice was not different
from that in Sham mice (pooled data from 6 and 18
hours) at 2 hours, but was decreased significantly at 4,
6, and 18 hours. The decline in RBF paralleled the
decline in systemic blood pressure and peritubular
capillary perfusion. GFR also declined significantly at 6
and 18 hours after CLP compared with that in Sham
mice (Figure 2B, inset).
Renal Vascular Permeability
Increased microvascular permeability and leakage is an
important pathogenic feature of vascular dysfunction as-
sociated with sepsis-induced organ injury.35 Using leak-
age of Evans Blue dye into the interstitial space as an
indicator of increased permeability, CLP caused a signif-
icant 4-fold increase in permeability as early as 2 hours
after CLP compared with sham operation (data from 6
hours in Sham mice) and a nearly 10-fold increase at 4
hours after CLP (Figure 2C). Thus, the increase in micro-
vascular permeability preceded the decline in RBF and
peritubular capillary perfusion, indicating that direct in-
jury to the renal microvasculature occurred before renal
hemodynamic failure.
Renal Tubular Epithelial Redox Stress and
Hypoxia
The time course of NADPH autofluorescence, an indica-
tor of cellular redox stress,24,25 is shown in Figure 3A.
Image analysis indicated that NADPH autofluorescence
intensity was significantly increased at 4 hours after CLP
compared with sham surgery (pooled data from 6 and 18
hours in Sham mice) and was sustained through 18
hours.
The severe decline in peritubular capillary perfusion
suggested a decline in oxygen delivery. To assess
renal tubular hypoxia, PIM-protein adducts were used
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images of PIM-protein adducts are shown in Figure 3B.
Few adducts were detected in Sham mouse kidneys,
whereas adducts were clearly visible in the tubules of
the cortex and cortico-medullary junction with little
staining in glomeruli as early as 4 hours after CLP, and
the amount of adducts appeared to increase by 6
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Figure 2. Effects of CLP on renal cortical peritubular capillary perfusion,
RBF, and capillary leakage. A: Time-dependent changes in the distribu-
tion of cortical peritubular capillaries with continuous, intermittent, or no
flow. CLP produced a significant decrease in the percentage of capillaries
with continuous flow and an increase in the percentage of capillaries with
no flow compared with Sham beginning at 4 hours. CLP also produced a
rapid time-dependent decrease in RBF (B) and decreased GFR (B, inset).
(C) Renal capillary permeability was assessed using Evans Blue dye
(Materials and Methods). CLP caused a significant increase in Evans Blue
dye leakage before the decline in capillary perfusion and RBF. Data are
given as mean  SEM for 6 to 11 mice per group (A), 5 to 11 mice per
group (B), 4 mice per group (B, inset), and 4 or 5 mice per group (C).
*P  0.05 compared with Sham.hours.ROS and RNS Generation by Renal Tubular
Cells after CLP
Oxidation of mitochondria-targeted MitoSOX23 by super-
oxide and other ROS was used to quantify ROS genera-
tion using IVVM. Image analysis demonstrated a time-
dependent increase in MitoSOX oxidation (Figure 4A),
which reached significance compared with Sham mice
(pooled data from 6 and 18 hours) at 4 hours. Representa-
tive images of the same field of view for FITC-dextran (cap-
illary perfusion) and MitoSOX are shown in Figure 4, B and
C, respectively. MitoSOX fluorescence was generally local-
ized to tubules bordered by capillaries with no flow.
Superoxide reacts with NO to generate the RNS per-
oxynitrite,36 which nitrates protein and oxidizes dihy-
drorhodamine to fluorescent rhodamine. Representative
immunohistochemical images for nitrotyrosine-protein
adducts in Sham and CLP mice at 6 and 18 hours are
shown in Figure 5A. At 6 hours after CLP, nitrotyrosine-
protein adducts were clearly evident in tubules in the
cortex. Adducts appeared to increase further by 18
hours. Staining in Sham mouse kidneys was not different
from the nonspecific staining control (data not shown).
Representative images captured during IVVM of the
same field of view for FITC-dextran and rhodamine are
shown in Figure 5B. As with MitoSOX fluorescence, rho-
damine fluorescence was generally localized to tubules
bordered by capillaries with no flow. Using image analy-
sis to quantify rhodamine fluorescence, we observed sig-
nificantly increased fluorescence density, which sug-
gested RNS generation at 6 and 18 hours after CLP
compared with sham surgery (Figure 5C).
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Figure 3. Time course of CLP-induced changes in renal NADPH levels and
PIM protein-adduct formation. A: Tubular NADPH levels were assessed using
IVVM. CLP produced a significant time-dependent increase in NADPH levels
beginning at 4 hours after CLP. Data are given as mean  SEM for 6 to 11
mice per group. *P  0.05 compared with Sham. B: Representative images
(200) from 3 or 4 mice per group of PIM-protein adducts. No specific
staining for PIM-protein adducts was apparent in Sham mice (6 hours after
surgery). Staining (brown) was visible at 4 hours after CLP, and was patchy
in the cortex. At 6 hours after CLP, staining was more intense and more
widespread throughout the cortex.
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AJP February 2012, Vol. 180, No. 2Delayed Treatment with MnTMPyP Restores
Peritubular Capillary Perfusion and Reduces
ROS/RNS Generation and Cellular Redox Stress
We first confirmed that MnTMPyP tetratosylate hydroxide
was an effective scavenger of superoxide by testing it
against xanthine oxidase–generated superoxide. MnTMPyP
produced a concentration-dependent scavenging of
superoxide with an IC50 of 1.18 mol/L (95% CI, 0.68–
2.04 mol/L). To evaluate the therapeutic potential of
MnTMPyP, a single dose (10 mg/kg i.p.) was adminis-
tered after the onset of sepsis because sepsis typically is
treated only after the onset of symptoms. We chose to
treat at 6 hours after CLP because this was the time of
greatest decline in renal capillary perfusion and the
peak of ROS generation in the cortical tubules. At 18
hours, MnTMPyP had no effect on cortical peritubular cap-
illary perfusion in Sham mice but reversed the decline in
perfusion in CLP mice (Figure 6A). Delayed treatment with
MnTMPyP also significantly reduced NADPH autofluores-
cence (Figure 6B), MitoSOX fluorescence (Figure 6C), and
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Figure 4. Time course of CLP-induced changes in cortical MitoSOX oxida-
tion. MitoSOX oxidation, an indicator of ROS generation, was assessed using
IVVM. A: Time course of the increase in MitoSOX fluorescence. CLP pro-
duced a significant increase in MitoSOX fluorescence beginning at 4 hours
after CLP. Data are given as mean SEM for 4 to 7 mice per group. *P 0.05
compared with Sham. B: Representative images from videos (200) of 4 to
6 mice per group of FITC-dextran to visualize the capillary vascular space.
Red blood cells are observed as shadows in the white capillary spaces.
Arrows indicate capillaries with no flow. C: Images of MitoSOX fluorescence
in the same fields of view as in B to compare the relationships between
capillary perfusion and MitoSOX fluorescence.nitrotyrosine-protein adducts (Figure 6D) at 18 hours, andinhibited rhodamine fluorescence by 89%  24% when
compared with CLP alone (n  3 to 6; P  0.05). In con-
trast, MnTMPyP did not reduce systemic NO genera-
tion [171  19 mol/L for CLP versus 151  26 mol/L
for CLP plus MnTMPyP administered at 6 hours (n  6;
P  0.05)], indicating that MnTMPyP acted down-
stream of NO synthesis.
Effects of Delayed Treatment with MnTMPyP on
Hemodynamics, Renal Function, and Tubular
Architecture
The effect of MnTMPyP administered at 6 hours after
surgery (10 mg/kg i.p.) on MAP and HR are shown in
Figure 7, A and B, along with Sham and CLP control data
redrawn from Figure 1, A and B, for reference. MnTMPyP
produced a slight but significant increase in MAP
in Sham mice but did not change MAP in CLP mice. In
contrast, MnTMPyP produced a slight but significant in-
crease in HR in both Sham and CLP mice. These data
suggest that the effects of MnTMPyP on renal capillary
perfusion were not due to changes in MAP.
MnTMPyP did not alter SCr or BUN levels in Shammice
at 18 hours (data not show). At 18 hours after CLP, SCr
(Figure 7C) and BUN (Figure 7D) concentrations were
both significantly elevated compared with those in Sham
mice at 18 hours. Delayed treatment with MnTMPyP signif-
icantly reduced both SCr and BUN concentrations; how-
ever, the increase in BUN was not completely blocked.
Inasmuch as SCr is not a reliable indicator of GRF in mice
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Figure 5. CLP-induced RNS generation in the kidney cortex. A: Represen-
tative images from 4 mice per group of the immunohistochemical staining for
nitrotyrosine-protein adducts. Staining in Sham-operated mouse kidneys was
not different from nonspecific staining (pre-incubation of the primary anti-
body with 10 mmol/L 3-nitrotyrosine; image not shown). Nitrotyrosine-
protein adducts (200; brown) were visible in the cortex but not the glom-
eruli at 6 hours after CLP. At 18 hours after CLP, nitrotyrosine-protein adducts
were widespread and clearly visible around tubules with morphologic dam-
age. Arrows indicate tubules with vacuolization. B: Representative images of
rhodamine fluorescence (oxidized DHR-123). Arrows indicate capillaries
with no flow identified via analysis of videos with FITC-dextran in the same
fields of view to compare the relationships between capillary perfusion and
RNS generation. C: Image analysis showed a significant increase in rhoda-
mine fluorescence at 6 and 18 hours compared with Sham. Data are given as
mean  SEM for 6 to 9 mice per group. *P  0.05.
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Delayed treatment with MnTMPyP partially but significantly
restored GFR (Figure 7E) and completely restored RBF
(Figure 7F). Representative images of PAS-stained cortical
sections for Sham 18 hours plus MnTMPyP, CLP 18 hours,
and CLP 18 hours plus MnTMPyP administered at 6 hours
are shown in Figure 7, G–I, respectively. The CLP 18-hour
group exhibited relatively mild morphologic renal dam-
age characterized by mild brush border loss, tubular
degeneration, and vacuolization in the early segments of
proximal tubules, as reported by us14,20 and by others.8
Delayed treatment with MnTMPyP significantly reduced
the morphologic injury score (Figure 7J).
Serum alanine aminotransferase concentration, a marker
of liver injury, in Sham, CLP, and CLP plus MnTMPyP mice
were 21 5, 85 16, and 33 6 IU/L, respectively (n 6
or 7; P 0.05 for CLP mice compared with Sham and CLP
plus MnTMPyP mice), indicating very mild hepatotoxicity,
which was also blocked by MnTMPyP.
Effects of Delayed Administration of MnTMPyP
on Survival
The ability of MnTMPyP to improve renal microcirculation
and restore renal function led us to investigate the poten-
tial of MnTMPyP to increase survival. Based on the re-
ported organ half-life for other metalloporphyrins in ro-
dents of 60 to 135 hours,38 CLP mice were given a single
dose of MnTMPyP (10 mg/kg i.p.) at 6 hours, and were
monitored through 48 hours (Figure 7K). Compared with
untreated CLP mice, MnTMPyP significantly prolonged
survival (P  0.01, Mantel-Cox log-rank test).
Effects of MnTMPyP on Initial Renal Injury
To assess its effects on the initial renal injury, MnTMPyP
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adducts(10 mg/kg i.p.) was administered at CLP. MnTMPyP sig-nificantly blocked MitoSOX fluorescence at 6 hours after
CLP, confirming that the dose was effective in scaveng-
ing ROS (Figure 8A). However, MnTMPyP failed to pre-
vent the initial declines in peritubular capillary perfusion
(Figure 8B) and RBF (Figure 8C) or the increase in cap-
illary leakage (Figure 8D).
Discussion
The hemodynamic changes associated with sepsis in-
clude progressive cardiovascular failure characterized
by systemic vasodilation, inadequate microvascular per-
fusion, and impairment of tissue oxygenation. While no
current animal models fully replicate all of the complexi-
ties of human sepsis, the CLP model in aged mice mimics
some key features of severe septic shock in humans
including release of cytokines with a similar magnitude
and kinetic profile,8,39 a decrease in MAP-associated
increased systemic NO production40 that is largely de-
pendent on up-regulation of inducible NO synthase,14,34
and similar renal tubular damage and decreased renal
function, which occur relatively rapidly and progress to
AKI.2,34,41 Still, a limitation of this model is that it does not
replicate the initial hyperdynamic circulation observed in
sepsis.42 Although this model of sepsis-induced AKI has
been used for a number of years,8 a detailed investiga-
tion of the changes in RBF, GFR, and peritubular capillary
perfusion during the course of sepsis has never been
performed.
We observed that RBF declined rapidly and dramatically
after CLP, paralleling the decrease in MAP. This is in con-
trast to what is observed in the sheep after Escherichia coli
infusion, where RBF increases over time43,44; however, in
pigs subjected to autologous fecal peritonitis, a model more
closely resembling CLP, RBF decreases slowly as MAP is
reduced.45,46 Because RBF in patients with sepsis is rarely
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AJP February 2012, Vol. 180, No. 2velopment of AKI in these critically ill patients are unknown.
In the few patients in whom RBF has been measured, high
variability in RBF among patients prevents reliable conclu-
sions about the state of RBF during the course of sepsis-
induced AKI.47,48
An important finding was how quickly renal capillaries
became damaged, likely as a result of cytokine-mediated
endothelial injury.49 Evidence of renal capillary leakage
after CLP in the mouse was first reported at 6 hours (the
earliest time point measured) by Yasuda et al26 Our data
demonstrate that capillary leakage occurs as early as 2
hours after CLP, just preceding the decline in RBF and
peritubular capillary perfusion. Whereas capillary leak-
age can contribute to reduced capillary perfusion,49 de-
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BAcreased systemic MAP and increased renal vascular re-sistance more likely have a greater effect on RBF,50 in
particular because MAP decreased to below the reported
autoregulatory pressure necessary to maintain GFR in the
mouse.33 Regardless of the cause, this combination of
events was associated with development of a hypoxic
pro-oxidant peritubular microenvironment and a de-
crease in GFR within 6 hours. The rapid decline in peri-
tubular capillary perfusion coincided with development of
localized areas of redox stress and hypoxia. Tubular gen-
eration of ROS was also temporally and spatially related
to the decline in capillary perfusion, as was generation of
peroxynitrite (the product of NO and superoxide) in the
peritubular microenvironment. At 18 hours after CLP, the
RBF, peritubular capillary perfusion, and GFR were still
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Figure 7. Effects of MnTMPyP on hemodynam-
ics, renal function, tubular architecture, and sur-
vival. MnTMPyP (10 mg/kg) administered at 6
hours after CLP, when GRF and RBF were de-
creased (see Figure 2). MAP (A) and HR (B) for
mice treated with MnTMPyP are shown, along
with Sham and CLP control data replotted from
Figure 1. MAP was increased in Sham plus
MnTMPyP mice (*P  0.05 compared with
Sham) but not in CLP plus MnTMPyP mice,
whereas HR was increased in both Sham plus
MnTMPyP and CLP plus MnTMPyP mice (*P 
0.05 compared with Sham and CLP, respec-
tively). Data are given as mean  SEM for 4 to 6
mice per group. Delayed treatment with MnT-
MPyP prevented the increase in SCr concentra-
tion (C) and partially but significantly reduced
serum BUN concentration (D). MnTMPyP also
reversed the decline in GFR (E) and RBF (F).
Data are given as mean  SEM for 4 to 8 mice
per group; *P  0.05 compared with Sham, †P 
0.05 compared with Sham, and CLP 18 hours
plus Vehicle. Representative images (200)
from 5 to 7 mice per group of PAS-stained cortex
are shown for Sham (G), CLP 18 hours plus
Vehicle (H), and CLP 18 hours plus MnTMPyP
(I) mice treated at 6 hours. Arrows indicate
representative tubules with vacuolization. J: De-
layed treatment with MnTMPyP also reduced the
tubular injury score. Data are plotted as individ-
ual scores with mean and range, and were ana-
lyzed using the Kruskal-Wallis test (*P  0.05
compared with Sham). K: Administration of
MnTMPyP in CLP mice at 6 hours resulted in a
significant improvement in survival compared
with that in untreated CLP control mice (*P 
0.01, Mantel-Cox log-rank test; n  10 mice per
group).8 h +
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AJP February 2012, Vol. 180, No. 2renal autoregulatory pressure, which suggests that the
sustained oxidant generation and tubular damage con-
tributed to the sustained renal hemodynamic failure as
noted in renal ischemic injury.51
CLP-induced AKI is not due to hemodynamic failure
alone (pre–renal AKI), which supports the emerging view
that renal microcirculatory failure and direct tubular in-
jury, even after correction of systemic hemodynamics,
contribute significantly to sepsis-induced AKI in hu-
mans.42 Targeting the early hemodynamic failure with the
objective of maintaining organ perfusion4 is not always
effective in preserving organ function because the effects
of the initial hemodynamic insult may be difficult to pre-
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Figure 8. Effects of MnTMPyP on the early renal effects of CLP. MnTMPyP
(10 mg/kg) administered at CLP blocked MitoSOX fluorescence at 6 hours
(A), but did not alter the decline in peritubular capillary perfusion (B), RBF
(C), or Evans Blue dye leakage (D). Data are given as mean  SEM for 4 to
6 mice per group. *P  0.05 compared with Sham.vent or reverse.52 Our data support the rationale for alsotargeting oxidant generation in the peritubular microen-
vironment10 because ROS and RNS generation by the tu-
bular epithelium are relatively later events clearly linked to
tubular injury. ROS and RNS can activate extracellular
matrix degrading enzymes,20,53 damage cellular mem-
branes,36 and inhibit mitochondrial function.54 These time
course studies suggest a rapid transition from the initial
capillary endothelial injury and renal hypoperfusion to a
predominantly oxidative stress–mediated tubular injury,
which then helps sustain the decline in renal capillary per-
fusion and renal function. A major finding of these studies is
that scavenging ROS and RNS, even if delayed, reverses
the decline in capillary perfusion and renal function.
Studies with the superoxide dismutase mimetic/per-
oxynitrite scavenger MnTMPyP17,18 revealed mechanistic
insights into early renal hemodynamic failure. Superoxide
and perhaps peroxynitrite mediate, at least in part, the
renal vasoconstrictor responses to endothelin and ang-
iotensin II55–57 and the loss in vasoreactivity in mesen-
teric microvessels from mice with sepsis.58 We observed
that MnTMPyP was unable to prevent renal capillary leak-
age and failed to preserve RBF or peritubular capillary
perfusion during the first 6 hours after CLP despite re-
ducing ROS levels, which suggests that these early renal
hemodynamic defects are not superoxide- or peroxyni-
trite-dependent. Nevertheless, MnTMPyP was able to
prevent tubular injury and actually reverse peritubular
capillary hypoperfusion at 18 hours even when adminis-
tered after the onset of renal hypoperfusion. This impor-
tant finding supports the notion that preventing tubular
injury may enable capillary perfusion to recover.14,15,59
The mechanism of recovery of the microcirculation is
unclear, but was not due to an increase in MAP because
MnTMPyP did not alter MAP in CLP mice despite slightly
increasing HR. The reason for this may be related to a
potential increase in the bioavailability of NO in resis-
tance vessels when superoxide levels are reduced.58
Recovery of the renal microcirculation was likely due to
the protection against oxidant-induced tubular epithelial
injury. As tubular swelling, cell sloughing, and membrane
damage occur, peritubular capillary perfusion is likely
impeded further. This would augment local hypoxia26
and oxidant generation to exacerbate tubular injury and
capillary dysfunction.15 Thus, MnTMPyP was able to
break the cycle of injury by protecting the tubular epithe-
lium and enabling recovery of capillary perfusion, RBF,
and renal function. Moreover, a single dose of MnTMPyP
administered at 6 hours after CLP dramatically improved
48-hour survival. Other metalloporphyrins likely share
these protective effects because pretreatment with
MnTE-2-PyP prevented the decline in RBF and GFR and
also improved survival in a lipopolysaccharide model of
sepsis.16 Growing evidence suggests that preserving re-
nal function during sepsis could reduce development of
multiple-organ failure and death.60 However, it is unlikely
that MnTMPyP acted only in the kidney. Inasmuch as
oxidative stress can occur in multiple organs during sep-
sis,10,61 MnTMPyP may have had direct protective effects
on other organs as well.
While the intracellular sources of ROS and RNS could
not be identified in these studies, the protective effects of
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AJP February 2012, Vol. 180, No. 2MnTMPyP suggest that mitochondrial oxidant generation
is at least one likely source10 because MitoSOX is tar-
geted to mitochondria23 and MnTMPyP blocked the in-
tracellular localization of both MitoSOX and rhodamine
fluorescence in tubules. Moreover, MnTMPyP protects
tubular epithelial mitochondria during renal ischemia and
reperfusion.62 Establishing the relative contributions of
ROS and RNS to renal injury will require absolutely selective
ROS and RNS scavengers, which are not yet available.
Nevertheless, the protective effects of inducible NO syn-
thase inhibitors in experimental models of sepsis also sup-
port the notion that RNS generation is critical to develop-
ment of sepsis-induced AKI.1,14,15,59
Another striking finding was the very early decline in
GRF, which persisted through 18 hours. Using inulin
clearance,19 we were able to detect a dramatic decline in
GRF at 6 hours, which is earlier than previously thought
based on SCr concentrations,8,14 now regarded as a
poor marker of renal function in sepsis due to reduced
production of creatinine by mice with sepsis.37 Although
MnTMPyP at the dose used only partially restored GFR,
the RBF and cortical peritubular capillary perfusion were
restored and tubular architecture was preserved. Thus,
oxidant generation in the peritubular microenvironment
can be added to the growing list of drug targets amena-
ble to delayed therapy in rodent models of sepsis-in-
duced AKI8,20,63–65 and provide proof-of-principle that
superoxide dismutase mimetics and peroxynitrite scav-
engers should be evaluated further as possible therapeu-
tic agents because targeting the later oxidant-damaging
effects in the microcirculation could have a high likeli-
hood of success in patients with sepsis.
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